Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Glenmark Life Sciences share price/ Glenmark Life Sciences Profit Loss Annual
Glenmark Life Sciences Profit & Loss Annual
Trade1,097.55 +48.65 (4.64%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 2,283.21 | 2,161.22 | 2,123.21 | 1,885.17 |
| Total Revenue | 2,283.21 | 2,161.22 | 2,123.21 | 1,885.17 |
| Costof Revenue Total | 1,002.01 | 1,014.09 | 1,042.89 | 905.50 |
| Gross Profit | 1,281.20 | 1,147.13 | 1,080.33 | 979.67 |
| Selling/ General/ Admin Expenses Total | 258.16 | 474.99 | 463.52 | 384.55 |
| Depreciation/ Amortization | 53.45 | 42.09 | 37.88 | 33.39 |
| Other Operating Expenses Total | 348.80 | 25.40 | -0.32 | -0.38 |
| Total Operating Expense | 1,662.42 | 1,560.30 | 1,543.97 | 1,323.06 |
| Operating Income | 620.79 | 600.93 | 579.25 | 562.10 |
| Interest Inc( Exp) Net- Non- Op Total | -15.46 | 282.74 | -135.05 | -904.99 |
| Other Net | 12.04 | -0.03 | -0.07 | -0.08 |
| Net Income Before Taxes | 631.29 | 628.61 | 564.93 | 470.94 |
| Provisionfor Income Taxes | 160.40 | 161.65 | 146.20 | 119.36 |
| Net Income After Taxes | 470.89 | 466.96 | 418.72 | 351.58 |
| Net Income Before Extra Items | 470.89 | 466.96 | 418.72 | 351.58 |
| Net Income | 470.89 | 466.96 | 418.72 | 351.58 |
| Income Availableto Com Excl Extra Ord | 470.89 | 466.96 | 418.72 | 351.58 |
| Income Availableto Com Incl Extra Ord | 470.89 | 466.96 | 418.72 | 351.58 |
| Diluted Net Income | 470.89 | 466.96 | 418.72 | 351.58 |
| Diluted Weighted Average Shares | 12.27 | 12.25 | 11.75 | 12.25 |
| Diluted EPS Excluding Extra Ord Items | 38.38 | 38.11 | 35.63 | 28.69 |
| Diluted Normalized EPS | 38.38 | 38.37 | 35.67 | 28.73 |
| Unusual Expense( Income) | - | 3.72 | - | - |
| Gain( Loss)on Saleof Assets | - | -5.58 | -7.43 | -5.84 |
| DPS- Common Stock Primary Issue | - | 21.00 | 21.00 | - |
*All figures in crores except per share values
Glenmark Life Sciences Quick Links
Glenmark Life Sciences Dividend Glenmark Life Sciences Bonus Glenmark Life Sciences News Glenmark Life Sciences AGM Glenmark Life Sciences Rights Glenmark Life Sciences Splits Glenmark Life Sciences Board Meetings Glenmark Life Sciences Key Metrics Glenmark Life Sciences Shareholdings Glenmark Life Sciences Balance Sheet Glenmark Life Sciences Cashflow Glenmark Life Sciences Q1 Results Glenmark Life Sciences Q2 Results Glenmark Life Sciences Q3 Results Glenmark Life Sciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)